One aspect that remains to be fully understood is how the higher levels of TERT expression and activity found in TERT-mutant cells provides a proliferative or other competitive advantage, since cancer cells typically have activated TERT expression to overcome the Hayflick limit long before TERT promoter mutations arise. This evidence concerns the gene TERT and cancer.